Healthcare [ 7/13 ] | Medical Devices [ 107/159 ]
NYSE | Common Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jan 30, 24 | 3.46 Increased by +15.33% | 3.27 Increased by +5.81% |
| Nov 2, 23 | 2.46 Increased by +16.04% | 2.43 Increased by +1.23% |
| Aug 3, 23 | 2.54 Increased by +12.89% | 2.38 Increased by +6.72% |
| May 1, 23 | 2.14 Increased by +8.63% | 2 Increased by +7% |
| Jan 31, 23 | 3 Increased by +10.7% | 2.84 Increased by +5.63% |
| Oct 31, 22 | 2.12 Decreased by -3.64% | 2.23 Decreased by -4.93% |
| Jul 26, 22 | 2.25 Increased by 0% | 2.28 Decreased by -1.32% |
| Apr 28, 22 | 1.97 Increased by +2.07% | 1.95 Increased by +1.03% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 5.82 B Increased by +11.78% | 1.14 B Increased by +103.02% | Increased by +19.66% Increased by +81.62% |
| Sep 30, 23 | 4.91 B Increased by +9.6% | 692 M Decreased by -15.2% | Increased by +14.1% Decreased by -22.62% |
| Jun 30, 23 | 5 B Increased by +11.2% | 738 M Increased by +12.5% | Increased by +14.77% Increased by +1.17% |
| Mar 31, 23 | 4.78 B Increased by +11.77% | 592 M Increased by +83.28% | Increased by +12.39% Increased by +63.99% |
| Dec 31, 22 | 5.2 B Increased by +10.66% | 563 M Decreased by -14.95% | Increased by +10.82% Decreased by -23.15% |
| Sep 30, 22 | 4.48 B Increased by +7.67% | 816 M Increased by +86.3% | Increased by +18.22% Increased by +73.03% |
| Jun 30, 22 | 4.49 B Increased by +4.63% | 656 M Increased by +10.81% | Increased by +14.6% Increased by +5.9% |
| Mar 31, 22 | 4.28 B Increased by +8.15% | 323 M Increased by +6.95% | Increased by +7.56% Decreased by -1.1% |
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.